Controls on the geochemistry of rare earth elements in sediments and groundwaters of the Aquia aquifer, Maryland, USA von Willis, Stephanie S., Johannesson, Karen H.

Volltext

Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)–based mutagenesis screen: high efficacy of drug combinations von Bradeen, Heather A., Eide, Christopher A., O'Hare, Thomas, Johnson, Kara J., Willis, Stephanie G., Lee, Francis Y., Druker, Brian J., Deininger, Michael W.

Volltext

A Half-Log Increase in BCR-ABL RNA Predicts a Higher Risk of Relapse in Patients with Chronic Myeloid Leukemia with an Imatinib-Induced Complete Cytogenetic Response von Press, Richard D, Galderisi, Chad, Yang, Rui, Rempfer, Carole, Willis, Stephanie G, Mauro, Michael J, Druker, Brian J, Deininger, Michael W N

Volltext

Characterization of antibiotic overuse for common infectious disease states at hospital discharge von Zodrow, Rebecca, Olson, Andrew, Willis, Stephanie, Grauer, Dennis, Klatt, Megan

Volltext

High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients von Tyner, Jeffrey W., Erickson, Heidi, Deininger, Michael W.N., Willis, Stephanie G., Eide, Christopher A., Levine, Ross L., Heinrich, Michael C., Gattermann, Norbert, Gilliland, D. Gary, Druker, Brian J., Loriaux, Marc M.

Volltext

High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy von Willis, Stephanie G., Lange, Thoralf, Demehri, Shadmehr, Otto, Sandra, Crossman, Lucy, Niederwieser, Dietger, Stoffregen, Eric P., McWeeney, Shannon, Kovacs, Ines, Park, Byung, Druker, Brian J., Deininger, Michael W.

Volltext

RNAi screen for rapid therapeutic target identification in leukemia patients von Tyner, Jeffrey W, Deininger, Michael W, Loriaux, Marc M, Chang, Bill H, Gotlib, Jason R, Willis, Stephanie G, Erickson, Heidi, Kovacsovics, Tibor, O'Hare, Thomas, Heinrich, Michael C, Druker, Brian J

Volltext

Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib von Press, Richard D., Willis, Stephanie G., Laudadio, Jennifer, Mauro, Michael J., Deininger, Michael W.N.

Volltext

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia von Levine, Ross L., Loriaux, Marc, Huntly, Brian J.P., Loh, Mignon L., Beran, Miroslav, Stoffregen, Eric, Berger, Roland, Clark, Jennifer J., Willis, Stephanie G., Nguyen, Kim T., Flores, Nikki J., Estey, Elihu, Gattermann, Norbert, Armstrong, Scott, Look, A. Thomas, Griffin, James D., Bernard, Olivier A., Heinrich, Michael C., Gilliland, D. Gary, Druker, Brian, Deininger, Michael W.N.

Volltext

A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib von McWeeney, Shannon K., Pemberton, Lucy C., Loriaux, Marc M., Vartanian, Kristina, Willis, Stephanie G., Yochum, Gregory, Wilmot, Beth, Turpaz, Yaron, Pillai, Raji, Druker, Brian J., Snead, Jennifer L., MacPartlin, Mary, O'Brien, Stephen G., Melo, Junia V., Lange, Thoralf, Harrington, Christina A., Deininger, Michael W.N.

Volltext

Absence of SKP2 expression attenuates BCR-ABL–induced myeloproliferative disease von Agarwal, Anupriya, Bumm, Thomas G.P., Corbin, Amie S., O'Hare, Thomas, Loriaux, Marc, VanDyke, Jonathan, Willis, Stephanie G., Deininger, Jutta, Nakayama, Keiichi I., Druker, Brian J., Deininger, Michael W.

Volltext

RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia von Tyner, Jeffrey W., Walters, Denise K., Willis, Stephanie G., Luttropp, Mary, Oost, Jason, Loriaux, Marc, Erickson, Heidi, Corbin, Amie S., O'Hare, Thomas, Heinrich, Michael C., Deininger, Michael W., Druker, Brian J.

Volltext

Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph+ALL: a Children's Oncology Group (COG) study von Chang, Bill H., Willis, Stephanie G., Stork, Linda, Hunger, Stephen P., Carroll, William L., Camitta, Bruce M., Winick, Naomi J., Druker, Brian J., Schultz, Kirk R.

Volltext

Arsenic and Antimony in Groundwater Flow Systems: A Comparative Study von Willis, Stephanie S, Haque, Shama E, Johannesson, Karen H

Volltext

Changes in extreme, cold-season synoptic precipitation events under global warming von Gutowski Jr, William J., Willis, Stephanie S., Patton, Jason C., Schwedler, Benjamin R. J., Arritt, Raymond W., Takle, Eugene S.

Volltext

BCR-ABL Kinase Domain Mutations in Chronic Myeloid Leukemia: Not Quite Enough to Cause Resistance to Imatinib Therapy? von Lange, Thoralf, Park, Byung, Willis, Stephanie G, Deininger, Michael W N

Volltext

Molecular phylogenetic and biogeochemical studies of sulfate-reducing Bacteria in the rhizosphere of Spartina alterniflora von HINES, M. E, EVANS, R. S, GENTHNER, B. R. S, WILLIS, S. G, FRIEDMAN, S, ROONEY-VARGA, J. N, DEVEREUX, R

Volltext

The Role of Empathy and Adult Attachment in Predicting Stigma toward Severe and Persistent Mental Illness and other Psychosocial or Health Conditions von Webb, Marcia, Peterson, Jessica, Willis, Stephanie C, Rodney, Heather, Siebert, Erin, Carlile, Jessica A, Stinar, Laurel

Volltext

In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl–positive cell lines von La Rosée, Paul, Johnson, Kara, Corbin, Amie S., Stoffregen, Eric P., Moseson, Erika M., Willis, Stephanie, Mauro, Michael M., Melo, Junia V., Deininger, Michael W., Druker, Brian J.

Volltext

BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib von Sherbenou, Daniel W., Hantschel, Oliver, Kaupe, Ines, Willis, Stephanie, Bumm, Thomas, Turaga, Lalita P., Lange, Thoralf, Dao, Kim-Hien, Press, Richard D., Druker, Brian J., Superti-Furga, Giulio, Deininger, Michael W.

Volltext